AGIO

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AGIO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/14	23 : 00	GlobeNewswire Inc.	Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/05/06	20 : 00	GlobeNewswire Inc.	Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/05/03	20 : 00	GlobeNewswire Inc.	Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/05/02	20 : 00	GlobeNewswire Inc.	Agios Reports Business Highlights and First Quarter 2024 Financial Results	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/04/18	20 : 00	GlobeNewswire Inc.	Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/04/09	20 : 00	GlobeNewswire Inc.	Agios Publishes 2024 Environmental, Social and Governance (ESG) Report	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/08	08 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/06	06 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/06	06 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/06	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/06	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/06	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/05	21 : 00	GlobeNewswire Inc.	Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/02	06 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/02	06 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/02	06 : 25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/02	06 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/03/01	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/28	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/27	11 : 21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/23	07 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/22	21 : 00	GlobeNewswire Inc.	Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/16	00 : 33	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	21 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	21 : 00	GlobeNewswire Inc.	Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	07 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	07 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	07 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	04 : 21	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AGIO	Agios Pharmaceuticals Inc
2024/02/15	04 : 06	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AGIO	Agios Pharmaceuticals Inc